CLINICAL_TRIALS
trial_result
· 2021-07-15
Clinical Trial Update: Safety and Efficacy Study of GRT6005 in Patients With Osteoarthritis (OA) Knee Pain [Phase 2]
Summary
Phase 2 clinical trial of GRT6005 in knee osteoarthritis has completed; safety and efficacy data were collected.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tris Pharma, Inc. | Conditions: Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee | Phase 2 | Status: COMPLETED